158 related articles for article (PubMed ID: 12130457)
1. Application of oral contrast media in coregistered positron emission tomography-CT.
Dizendorf EV; Treyer V; Von Schulthess GK; Hany TF
AJR Am J Roentgenol; 2002 Aug; 179(2):477-81. PubMed ID: 12130457
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
Sun XG; Huang G; Liu JJ; Wan LR
Hell J Nucl Med; 2009; 12(2):115-8. PubMed ID: 19675862
[TBL] [Abstract][Full Text] [Related]
3. Initial experience with oral contrast in PET/CT: phantom and clinical studies.
Cohade C; Osman M; Nakamoto Y; Marshall LT; Links JM; Fishman EK; Wahl RL
J Nucl Med; 2003 Mar; 44(3):412-6. PubMed ID: 12621008
[TBL] [Abstract][Full Text] [Related]
4. Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials.
Antoch G; Freudenberg LS; Stattaus J; Jentzen W; Mueller SP; Debatin JF; Bockisch A
AJR Am J Roentgenol; 2002 Dec; 179(6):1555-60. PubMed ID: 12438054
[TBL] [Abstract][Full Text] [Related]
5. Oral contrast medium in PET/CT: should you or shouldn't you?
Groves AM; Kayani I; Dickson JC; Townsend C; Croasdale I; Syed R; Nagabushan N; Hain SF; Ell PJ; Bomanji JB
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1160-6. PubMed ID: 15937685
[TBL] [Abstract][Full Text] [Related]
6. The effect of oral contrast on large bowel activity in FDG-PET/CT.
Otsuka H; Graham MM; Kubo A; Nishitani H
Ann Nucl Med; 2005 Apr; 19(2):101-8. PubMed ID: 15909489
[TBL] [Abstract][Full Text] [Related]
7. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.
Nehmeh SA; Erdi YE; Kalaigian H; Kolbert KS; Pan T; Yeung H; Squire O; Sinha A; Larson SM; Humm JL
J Nucl Med; 2003 Dec; 44(12):1940-4. PubMed ID: 14660720
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of low-density neutral oral contrast material in PET/CT for tumor imaging: results of a randomized clinical trial.
Otero HJ; Yap JT; Patak MA; Erturk SM; Israel DA; Johnston CJ; Sakellis C; Rybicki FJ; Van den Abbeele AD; Ros PR
AJR Am J Roentgenol; 2009 Aug; 193(2):326-32. PubMed ID: 19620427
[TBL] [Abstract][Full Text] [Related]
9. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
[TBL] [Abstract][Full Text] [Related]
10. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
[TBL] [Abstract][Full Text] [Related]
11. Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps.
Delbeke D; Martin WH; Patton JA; Sandler MP
Radiology; 2001 Jan; 218(1):163-71. PubMed ID: 11152796
[TBL] [Abstract][Full Text] [Related]
12. Effective methods to correct contrast agent-induced errors in PET quantification in cardiac PET/CT.
Büther F; Stegger L; Dawood M; Range F; Schäfers M; Fischbach R; Wichter T; Schober O; Schäfers KP
J Nucl Med; 2007 Jul; 48(7):1060-8. PubMed ID: 17574981
[TBL] [Abstract][Full Text] [Related]
13. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
14. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.
Mawlawi O; Erasmus JJ; Munden RF; Pan T; Knight AE; Macapinlac HA; Podoloff DA; Chasen M
AJR Am J Roentgenol; 2006 Feb; 186(2):308-19. PubMed ID: 16423932
[TBL] [Abstract][Full Text] [Related]
15. Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer.
An YS; Sheen SS; Oh YJ; Hwang SC; Yoon JK
Ann Nucl Med; 2007 Dec; 21(10):585-92. PubMed ID: 18092135
[TBL] [Abstract][Full Text] [Related]
16. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H
Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
[TBL] [Abstract][Full Text] [Related]
17. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.
Beyer T; Antoch G; Bockisch A; Stattaus J
J Nucl Med; 2005 Mar; 46(3):429-35. PubMed ID: 15750155
[TBL] [Abstract][Full Text] [Related]
18. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging.
Antoch G; Jentzen W; Freudenberg LS; Stattaus J; Mueller SP; Debatin JF; Bockisch A
Invest Radiol; 2003 Dec; 38(12):784-9. PubMed ID: 14627896
[TBL] [Abstract][Full Text] [Related]
20. Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies.
Nakamoto Y; Chin BB; Kraitchman DL; Lawler LP; Marshall LT; Wahl RL
Radiology; 2003 Jun; 227(3):817-24. PubMed ID: 12773683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
